Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation

Response by David Taggart, MD, PhD to the EXCEL Statement

Presenter: David Taggart

December 19, 2019

Presentation TCT 2019

V-Wave for HFrEF and HFpEF

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Late Benefits From BVS: Theory and Evidence

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

TCT 2019 Linnemeier Young Investigator Award Presentation

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Which Patients Are (and Are Not) Candidates for Intravenous Platelet Inhibition During PCI?

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Welcome and Introduction

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

SSO2 Therapy: Clinical Evidence and Outcomes

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

Current Landscape and Future Directions: Intracardiac Shunts, Ventricular Remodeling Therapies

Presenter: Gregg Stone

September 25, 2019

Presentation TVT 2019

TMVR Pivotal Trial Designs in the COAPT Era

Presenter: Gregg Stone

June 14, 2019

Presentation TVT 2019

COAPT: Perspectives on Clinical Trial Data and Anticipated US Patient Selection Criteria for FMR

Presenter: Gregg Stone

June 14, 2019

Presentation TVT 2019

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

Presenter: Gregg Stone

June 13, 2019

Presentation TVT 2019

V-Wave

Presenter: Gregg Stone

June 12, 2019

Presentation Fellows 2019

Stent Technology:Past, Present and Future

Presenter: Gregg W. Stone

April 12, 2019

Advertisement

Response by David Taggart, MD, PhD to the EXCEL Statement

V-Wave for HFrEF and HFpEF

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Late Benefits From BVS: Theory and Evidence

EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

TCT 2019 Linnemeier Young Investigator Award Presentation

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

Which Patients Are (and Are Not) Candidates for Intravenous Platelet Inhibition During PCI?

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Welcome and Introduction

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

SSO2 Therapy: Clinical Evidence and Outcomes

Current Landscape and Future Directions: Intracardiac Shunts, Ventricular Remodeling Therapies

TMVR Pivotal Trial Designs in the COAPT Era

COAPT: Perspectives on Clinical Trial Data and Anticipated US Patient Selection Criteria for FMR

A Synthesis of COAPT, MitraFR, and Other FMR Trials: Clinical Implications

V-Wave

Stent Technology:Past, Present and Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content